Drug Profile
PS 938285
Alternative Names: PS-938285Latest Information Update: 11 Jul 2007
Price :
$50
*
At a glance
- Originator Pharmacopeia Drug Discovery; Schering-Plough
- Class
- Mechanism of Action Interleukin 8B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 11 Jul 2007 Discontinued - Phase-I for Respiratory tract disorders in USA (unspecified route)
- 24 May 2005 This compound is still in active development
- 12 Jan 2004 Phase-I clinical trials in Respiratory tract disorders in USA (unspecified route)